Myelodysplastic Syndromes
Showing NaN - NaN of 60
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- Panobinostat (LBH589)
- 5-Azacytidine
-
Augusta, Georgia
- +37 more
Jul 20, 2020
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Withdrawn
- Leukemia
- +4 more
- alemtuzumab
- +6 more
-
La Jolla, California
- +23 more
Nov 25, 2019
MDS Trial in Germany, United States (lenalidomide)
Completed
- Myelodysplastic Syndromes
-
Scottsdale, Arizona
- +31 more
Nov 6, 2019
MDS Trial in United States (Atezolizumab, Azacitidine)
Completed
- Myelodysplastic Syndromes
-
Duarte, California
- +14 more
Aug 15, 2019
Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- Myelodysplastic Syndromes
- anti-thymocyte globulin
- +7 more
-
Los Angeles, California
- +5 more
Jul 1, 2019
Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Prexasertib
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 10, 2019
Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)
Terminated
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Phoenix, Arizona
- +5 more
Oct 17, 2018
Acute Myeloid Leukemia, MDS Trial in Boston, New York (RO6870810)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Boston, Massachusetts
- +1 more
Dec 7, 2017
Acute Myeloid Leukemia, MDS Trial in Los Angeles, Boston, New York (Itraconazole, PKC412)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Los Angeles, California
- +3 more
Aug 7, 2017
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- busulfan
- +12 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 20, 2017
GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +4 more
- cyclophosphamide
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 30, 2017
Leukemia, MDS Trial in United States (topotecan HCl)
Completed
- Leukemia
- Myelodysplastic Syndromes
- topotecan hydrochloride
-
Birmingham, Alabama
- +47 more
Jul 19, 2016
Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic Trial in France, United States
Completed
- Leukemia, Myelocytic, Acute
- +3 more
- Tacrolimus
- +2 more
-
Duarte, California
- +23 more
Feb 8, 2016
Bone Marrow Transplantation, Blood Disease, Hematopoietic Stem Cell Transplantation Trial in United States (fluconazole,
Completed
- Bone Marrow Transplantation
- +6 more
- fluconazole
- +4 more
-
Duarte, California
- +15 more
Feb 17, 2016
Anemia, MDS Trial in United States (Erythropoietin, Filgrastim, Transfusion)
Completed
- Anemia
- Myelodysplastic Syndromes
- Erythropoietin
- +2 more
-
Denver, Colorado
- +27 more
Oct 6, 2015
Leukemia, MDS Trial in Israel, United States (filgrastim, sargramostim, cytarabine)
Completed
- Leukemia
- Myelodysplastic Syndromes
- filgrastim
- +5 more
-
Scottsdale, Arizona
- +91 more
Jun 1, 2015
Leukemia, MDS Trial in United States (anti-thymocyte globulin, cyclosporine)
Completed
- Leukemia
- Myelodysplastic Syndromes
- anti-thymocyte globulin
- cyclosporine
-
Mobile, Alabama
- +93 more
Mar 5, 2015